Benmed Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 07-07-2024
- Paid Up Capital ₹ 2.74 M
as on 07-07-2024
- Company Age 32 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.55 Cr
as on 07-07-2024
- Revenue 2.82%
(FY 2022)
- Profit 41.67%
(FY 2022)
- Ebitda -265.43%
(FY 2022)
- Net Worth -147.77%
(FY 2022)
- Total Assets -6.56%
(FY 2022)
About Benmed Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.74 M.
The company has closed loans amounting to ₹4.55 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anju Tibrewal, Mamta Tibrewal, and Shweta Tibrewal serve as directors at the Company.
- CIN/LLPIN
U51397WB1992PTC054936
- Company No.
054936
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Benmed Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anju Tibrewal  | Additional Director | 30-Jun-2023 | Current |
| Mamta Tibrewal | Additional Director | 30-Jun-2023 | Current |
| Shweta Tibrewal | Additional Director | 30-Jun-2023 | Current |
Financial Performance of Benmed Laboratories.
Benmed Laboratories Pvt Ltd, for the financial year ended 2022, experienced modest growth in revenue, with a 2.82% increase. The company also saw a substantial improvement in profitability, with a 41.67% increase in profit. The company's net worth observed a substantial decline by a decrease of 147.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Benmed Laboratories?
In 2022, Benmed Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bangiya Gramin Vikash Bank Creation Date: 26 May 2010 | ₹2.13 Cr | Satisfied |
Oriental Bank Of Commerce Creation Date: 09 Nov 2006 | ₹1.50 Cr | Satisfied |
Canara Bank Creation Date: 25 Jun 2001 | ₹4.70 M | Satisfied |
How Many Employees Work at Benmed Laboratories?
Benmed Laboratories has a workforce of 3 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Benmed Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Benmed Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
